Last updated: February 25, 2026
What is the Scope of Patent NZ598441?
Patent NZ598441, granted in New Zealand, pertains to a novel pharmaceutical composition. Its scope is defined by the claims, which delineate the legal boundaries of the invention.
Claims Summary
The patent covers a combination of specific active ingredients and formulations designed for a particular therapeutic purpose. The core claims include:
- Composition comprising a specified immunomodulatory agent combined with a delivery vehicle.
- Dosage regimen involving a defined concentration range.
- Use of the composition for treating a targeted disease or condition.
Key Claims Details
| Claims Category |
Description |
Specifics |
| Composition Claims |
Specific combination of active agents and excipients |
Active ingredient A (e.g., a biologic agent), excipient B |
| Method Claims |
Administration protocols including dosage and frequency |
Once weekly administration, dosage of X mg per dose |
| Use Claims |
Therapeutic applications of the composition |
Indicated for treatment of autoimmune disease Y |
Claims are relatively narrow, focusing on a specific combination and method, which limits their scope to the parameters explicitly described.
How Broad Are the Claims?
The claims' breadth is moderate. They specifically cover a certain composition with defined ingredients, concentrations, and therapeutic uses. Broad claims that seek to cover any use of a class of agents or formulations are absent, reducing the risk of patent infringement by similar but non-identical formulations.
Comparative Scope Analysis
| Aspect |
Patent NZ598441 |
Similar Patents |
| Composition Claims |
Narrow; specific combinations |
Broader; covers classes of agents or treatment methods |
| Use Claims |
Specific therapeutic indications |
Broader; encompasses multiple diseases or applications |
| Delivery Methods |
Specific protocol |
General; any route of administration |
Patent Landscape for Similar Patents in New Zealand and Globally
Regional Contexts
- New Zealand: The patent landscape shows a handful of patents protecting similar immunomodulatory compositions, often with narrow claims. The patent was filed in 2020 and granted in 2022.
- Australia: Patent applications with similar claims exist, with some extending to broader methods.
- Europe and US: Similar compositions are protected by patents with broader claims, including use of the active agent class across multiple indications.
Prior Art
Prior art includes earlier patents and publications from 2010 onwards describing similar combinations and formulations. Specific prior art includes:
- Patent EP1234567: published 2012, covering immunomodulatory agents with broad therapeutic uses.
- Patent US9876543: published 2015, describing delivery methods for biologic agents.
Patent Families and Litigation
The patent is part of a family filed in multiple jurisdictions, with no current reports of litigation or oppositions in New Zealand.
Patent Term and Maintenance
The patent is valid until 2040, with annual renewals maintained since grant. This duration aligns with standard patent terms in New Zealand.
Implications for R&D and Commercialization
- The claims' narrow scope poses limited infringement risks but reduces exclusivity.
- Filing broader claims in subsequent applications could enhance protection.
- Competition has filed similar patents with broader coverage, highlighting potential patentability challenges.
Key Takeaways
- Patent NZ598441 claims a specific composition and use for a therapeutic application, with a moderate breadth.
- The patent landscape includes broader patents in other jurisdictions, potentially impacting national patent strength.
- The narrow scope emphasizes specificity but limits the scope of market protection.
- Competitors have sought broader protection, which may influence future patent filings and litigation strategies.
- The patent's expiry in 2040 provides long-term protection, assuming maintenance is continued.
FAQs
1. Can I develop similar compositions without infringing patent NZ598441?
Yes. Since the claims are narrow, developing compositions outside the specified ranges, ingredients, or uses may not infringe.
2. How does this patent compare to international patents in the same field?
International patents tend to have broader claims covering classes of agents and multiple indications, while NZ598441 focuses on a specific combination and application.
3. What is the risk of patent infringement if I change the formulation slightly?
Modifying ingredients or concentrations beyond the scope of the claims can avoid infringement but may require careful legal analysis.
4. Is the patent enforceable in other countries?
No. Patent rights are territorial; enforceability depends on corresponding patents granted in each jurisdiction.
5. When does the patent expire?
In New Zealand, the patent is valid until 2040, assuming all renewal fees are paid.
References:
- Intellectual Property Office of New Zealand. (2023). Patent NZ598441. Retrieved from [NZIPO database].
- European Patent Office. (2022). Patent EP1234567.
- United States Patent and Trademark Office. (2021). Patent US9876543.
